Particular matters of viral hepatitis in to Amazon Juan Miguel Villalobos-Salcedo (Bra) Universidade Federal de Rondônia FIOCRUZ-RO

Similar documents
Hepatitis B and C Basics

Hepatitis B and C in the Spotlight: A public health response in the Americas. Key Messages

1. YELLOW FEVER BACKGROUND 2. YELLOW FEVER IN SOUTH AMERICA

Regional Update Pandemic (H1N1) 2009 (December 1, h GMT; 12 h EST)

Challenges for viral hepatitis prevention in Latin American

Everything you ever wanted to know about Zika Virus Disease

Regional Update Pandemic (H1N1) 2009 (January 19, h GMT; 12 h EST)

AEDES AEGYFTI AS A FACTOR IN THE INTERNATIONAL SPREAD OF YELLOW FEVER. Statement presented by the Delegations of Brazil, Cuba and Panama

Viral Hepatitis B and C in North African Countries

EPIDEMIOLOGICAL HETEROGENEITY OF INFECTIONS WITH HEPATITIS B AND D VIRUSES IN BRAZIL

Academic Research in LA

HIBA ABDALRAHIM Capsca Focal Point Public Health Authority

Science & Technologies ADVANCED TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS C

Cutaneous Leishmaniasis : Global overview

Media centre. WHO Hepatitis B. Key facts. 1 of :12 AM.

Identification of patients with chronic hepatitis B/C the UK

CFR Backgrounders. The Zika Virus. 1 of :58. Author: Danielle Renwick, Copy Editor/Writer February 12, 2016.

Logistic problems to face Delta Hepatitis in the Amazonian Countries

Pandemic (H1N1) (August 28, h GMT; 12 h EST) Update on the qualitative indicators

Viral Hepatitis. WHO Regional Office for Europe July 2013

Regional Update Pandemic (H1N1) 2009 (March 15, h GMT; 12 h EST)

A Retrospective Study on Seroprevalence of Hepatitis B Surface Antigen among Patients in a Tertiary Care Hospital, South India

Pandemic (H1N1) (August 14, h GMT; 12 h EST) Update on the Qualitative Indicators

NIH Consensus Conference Statement. Management of Hepatitis C. March 24-26, NIH Web site. Available at:

Hepatitis B Vaccination and Prevention. Angela M. Jo, MD, MSHS

Estimates of PI*S and PI*Z Alpha-1 antitrypsin deficiency alleles prevalence in the Caribbean and North, Central and South America

Hepatitis STARS Program. Geri Brown, M.D. Associate Professor Department of Internal Medicine October 4, 2003

WASHINGTON STATE COMMUNICABLE DISEASES OF PUBLIC HEALTH SIGNIFICANCE FOR THE CIVIL SURGEON

Epidemiology of Acute Hepatitis C Infection in Canada Results from the Enhanced Hepatitis Strain Surveillance System (EHSSS)

We need to know who is at risk of Hepatitis B and C infections so that we can identify them and offer them testing. Primary care has important roles

Fact sheet. Yellow fever

Sandi Mitchell Nurse Educator Clinical Prevention Services BCCDC

Regional Update Pandemic (H1N1) 2009

Regional Update Pandemic (H1N1) 2009

Viral Hepatitis. Viral Hepatitis. Infectious Disease Epidemiology BMTRY 713 Viral Hepatitis. March 23, Selassie AW (DPHS, MUSC) 1

Regional Update Influenza (August 16, h GMT; 12 h EST)

FIRST CONFIRMED CASE OF IMPORTED ZIKA VIRUS IN HOUSTON, TEXAS. Preventing Transmission

Regional Update Pandemic (H1N1) 2009 (July 6, h GMT; 12 h EST)

Detection of Hepatitis B and C in Primary Care

APPROACH TO A PATIENT WITH CHRONIC HEPATITIS B INFECTION. Dr. Mohammad Zahiruddin Associate Professor Department of Medicine Dhaka Medical College

HIV/AIDS IN FOREIGN-BORN NEW YORKERS

Lifetime risk of infection >60% Early childhood infections common

Probiotics in Latin America. Regulation, Market and Trends

Rubella and CRS Elimination in the Americas

July World Hepatitis Day

Progress Toward Rubella and Congenital Rubella Syndrome Elimination in the Western Hemisphere,

GSK VACCINES: KEY GROWTH DRIVERS

Uses and Misuses of Viral Hepatitis Testing. Origins of Liver Science

Estimating the global burden of tuberculosis. WHO estimates of TB incidence, prevalence and mortality, by country,

Lessons Learned and Best Practices of Achieving and Maintaining Measles and Rubella Elimination in the Americas

JMSCR Volume 03 Issue 01 Page January 2015

Practical Solutions to Reduce Incidence of Liver Cancer. Nancy Steinfurth, Executive Director Liver Health Connection November 2017

An Update HBV Treatment

Spider monkey in Taricaya

Annex 2 A. Regional profile: West Africa

CANCER FACT SHEETS: LIVER CANCER

Module Two History and Incidence

Cotton Trade 02/03 03/04 04/05 05/06 06/07 07/08 08/09 09/10 10/11 11/12 12/13

Epidemiology of HCV infection among HD pts in Iran and prevention strategies

Global Reporting System for Hepatitis (GRSH) An introduction. WHO Global Hepatitis Programme

Hepatocellular Carcinome A REAL PROBLEM IN LATIN AMERICA

REGIONAL OVERVIEW AND PERSPECTIVES ON SOCIAL DETERMINANTS OF HEALTH IN AFRICA

Oncology in Emerging Markets

*This response is constantly evolving and recommendations in this presentation may change over time, please call your district epidemiologist or a

Notes Setting the Scene

Seizures of ATS (excluding ecstasy ), 2010

Influenza Update N 162

EAST LONDON INTEGRATED CARE

Portland Area Health Priorities

26/09/2014. Types of Viral Hepatitis. Prevention of Viral Hepatitis as a Health Disparity for American Indians: Successes and Challenges

Regional Update Pandemic (H1N1) 2009 (July 31, h GMT; 17 h EST) Update on the Qualitative Indicators Epidemiological Week 29 intensity

JMSCR Vol 3 Issue 10 Page October 2015

20. The purpose of this document is to examine the pre-pandemic efforts and the response to the new influenza A (H1N1) virus since April 2009.

SEROPREVALENCE OF HEPATITIS B AND C VIRUS INFECTIONS AMONG LAO BLOOD DONORS

3.1 PHASE 2 OF THE GLOBAL PROJECT

Regional Update Pandemic (H1N1) 2009 (July 19, h GMT; 12 h EST)

End Stage Liver Disease & Disease Specific Indications for Liver Transplant. Susan Kang, RN, MSN, ANP-BC

End Stage Liver Disease & Disease Specific Indications for Liver Transplant Susan Kang, RN, MSN, ANP BC

Eliminating Chronic Hepatitis B Disparities among Asian Pacific Islanders: A Model for Transforming Public Health in the Pacific

New Pods Published. Contents. Please click the relevant hyperlink to view the latest releases.

Vector Newcastle vaccine usage in Latin America. Luiz Sesti, Technical Services Latin America Ceva, Brazil

U.S. Preventive Services Task Force

Drug Use Around the World

WORLD DRUG REPORT 2011

CURRENT TREATMENT. Mitchell L Shiffman, MD Director Liver Institute of Virginia Bon Secours Health System Richmond and Newport News, Virginia

Chikungunya: Perspectives and Trends Global and in the Americas. Presenter: Dr. Eldonna Boisson PAHO/WHO

Social Studies 4 8 (118)

Page 1 of 6. Hepatitis B Virus (HBV) PRESENTATION RECOMMENDED IMMMUNOSUPRESSIVE TREATMENT TEST RESULTS. Obtain baseline HBV DNA level

ZIKA Virus and Mosquito Management. ACCG Rosmarie Kelly, PhD MPH 30 April 16

Sustaining Immunization in Developing Countries: The Future We Make

Viral Hepatitis: Biogeography and Pathogenesis

How does HBV affect the liver?

Hepatitis B vaccination worldwide: Lessons learnt and the way forward

Epidemiological Update Diphtheria

DR. CLAUDINA E. CAYETANO REGIONAL MENTAL ADVISOR Pan-American Health Organization/ World Health Organization

Regional Update Pandemic (H1N1) 2009 (May 24, h GMT; 12 h EST)

Hepatitis B: A Preventable Cause of Liver Cancer. Saira Khaderi MD, MPH Assistant Professor of Surgery Associate Director, Project ECHO June 17, 2016

Origin of CCR5-Delta 32 Mutation. Name Date

Swiss Summary of the Risk Management Plan (RMP) for. Vosevi, film-coated tablets

Viral Hepatitis - Historical Perspective

Transcription:

Juan Miguel Villalobos-Salcedo (Bra) Universidade Federal de Rondônia FIOCRUZ-RO

Historical and geographical particularities: Particular matters for Region Population with unique characteristic: Distribution and concentration Viral particular aspects Clinical presentation Treatment difficulties

Geographical particularities: Largest forest region and hydrographic basin of the world Northern hemisphere in South America 42% to Brazilian national territory Guyana, Venezuela, Colombia, Ecuador, Peru and Bolivia 6 million km 2

Historical particularities: biodiversity created 6 million years ago Result of climate changes, interactions between species and geological factors Elevation of mountains and creation of Andes mountains River was created 40 thousand years

Historical particularities: Between 20,000 and 12,000 bc - first human groups from Asia arrived to South America 7,000 and 6,000 years ago climatic and environmental changes 5,000 years ago second phase of human settlement - new socio-cultural practices RAINFOREST CULTURE

Historical particularities: Third phase occupation European settlement Legendary and mythical El Dorado Francisco Orellana called region Extractive action behind gold from forest Contact Spanish/Portuguese with Natives Indians

Historical particularities: Portuguese colonization Forte do Presépio Slave for Amerindians - miscegenation Rise to population CABOCLA Second half 18 th century arrival of blacks brought from Africa as slaves

Historical particularities: 19 th century systematic occupation Conquest territories of Amapa, Roraima and Acre Industrial Revolution vulcanization of Rubber New immigration waves of Europeans Arrival of Northeast rubber soldiers

Population with unique characteristic: Distribution and concentration Legal Extension 5,109,812 km 2-60% national territory 21,056,532 inhabitants -12,4% national population 4,14 hab/km 2 - lowest population density in the country

6 million km 2 Six countries 21 million hab. 12.4% population 4.14 hab/km2 60% territory

Viral particular aspects: Hepatitis B virus epidemiologic and virological particularities Hepatitis C virus genotyping particularities Hepatitis Delta virus clinical aspects particularities

Viral particular aspects: Hepatitis B virus epidemiologic particularities

HBV epidemiologic particularities: Intrafamilial transmission of HBV Possibly associated with presence of HBV carrier Shared use of toothbrushes

Viral particular aspects: Hepatitis B virus virological particularities

HBV virological particularities: Population group of Eastern region of Brazil Genotype A was the most commonly found 89.1%

Viral particular aspects: Hepatitis B virus virological particularities

HBV virological particularities: Population group of Western region of Brazil A (37.1%), D (42.8%), F (20.0%)

Viral particular aspects: Hepatitis C virus epidemiologic particularities

HCV epidemiological particularities: Prevalence of HCV infection (molecular biology) 2.5% in some areas of Acre state Probably associated with parenteral nonsecure injection High transmission is not recent

Viral particular aspects: Hepatitis C virus genotyping particularities

HCV Epidemiologic particularities: Genotype 1b - most prevalent (50%) Genotype 1a (27.2%) Genotype 2b (13.6%) and 3a (9.0%)

Viral particular aspects: Hepatitis D virus clinical presentation particularities

Man (65%), age less than 35 age (56%), Amerindians (21%) Risk factor household contact (50%) Dental treatment (43%) Birthplace Region (87%)

Majority patients has chronic hepatitis with hepatocellular injury Portal hypertension and/or low blood cells count Leukopenia (36.7%), thrombocytopenia (36.7%) and anemia (23.4%) Hypersplenism secondary signals

CONCLUSION: Exist particular matters for Region Population with unique characteristic Exist some viral particular aspects Clinical presentation Treatment difficulties